Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):151–156. doi: 10.1007/s00534-012-0560-4

Robotic Surgery – Improved Tool for Major Liver Resections?

Gerard J Abood 1, Allan Tsung 2,*
PMCID: PMC3566294  NIHMSID: NIHMS411350  PMID: 23053356

Abstract

Minimally-invasive liver surgery has recently undergone an explosion in the reported worldwide experience. Given its comparable outcomes to its open counterpart, high volume centers are utilizing minimal access liver surgery more frequently under well-defined criteria. The recent introduction of robotic-assisted surgery has further revolutionized the field of minimally invasive surgery and has expanded the reach of feasibility. Robot-assisted surgery was developed to help overcome the disadvantages of conventional laparoscopic surgery. As a result, there has been an increase in the reporting of advanced robot-assisted liver resections. A literature review was performed to identify the current manuscripts describing robotic liver surgery. Nine case series were identified, yielding 144 unique patient characteristics. Outcomes indicate that robot-assisted liver resection is feasible and safe for both minor and major liver resections in regards to EBL, LOS, and complications. Early data also suggests that robot liver surgery is efficacious in regards to short-term oncologic outcomes. Future studies will be needed to better evaluate advantages and disadvantages to laparoscopic liver resections.

Keywords: Robotic liver resection, laparoscopic liver resection, robotic hepatectomy, robotic surgery, liver surgery

INTRODUCTION

Minimally-invasive surgery has evolved dramatically since the first laparoscopic cholecystectomy was reported by Mühe in 1985.(1) Thanks in part to the acquisition of advanced laparoscopic skills and improved instrumentation, nearly all fields of surgery have seen the open counterpart achieved through minimal access surgery. As a result, reduction of hospital stay, improvement in cosmetic results, and decreased postoperative pain has been demonstrated in nearly all the surgical specialties when compared with conventional open operations. (25)

Laparoscopic liver surgery was first reported in 1992(6). Over the next 15 years, several case series reporting results of biopsises and small wedge resections, as well as resections of the left lateral section or anterior hepatic segments (segments 4b, 5,6) were reported with results consistent with the previously published benefits of minimally invasive surgery. Following the Cherqui et al report of a prospective cohort of 30 patients(7), numerous reports have been published further supporting the feasibility and adequacy of laparoscopic liver resection.(8) Recently, reports of anatomic laparoscopic liver resections – left and right hepatectomies, left lateral sectionectomy, and even extended left and right hepatectomy, have demonstrated the feasibility of such advanced resections.(911)

In an effort to standardize and summarize the current world position on laparoscopic liver surgery, a consensus conference was convened in 2008.(12) World experts agreed that laparoscopic liver surgery is a safe and effective approach to the management of surgical liver disease in the hands of trained surgeons with experience in hepatobiliary and laparoscopic surgery. Furthermore, the members of the consensus consortium agreed on the following as guidelines: 1. The best indications for laparoscopic liver resection are in patients with solitary lesions, 5 cm or less, located in the peripheral liver segments (segments 2–6); 2. The laparoscopic approach to the left lateral sectionectomy should be considered the standard of care; 3. Although most types of liver resection can be performed laparoscopically, including major liver resections, these should be reserved to experienced surgeons already facile with more complex laparoscopic resections.

Robot-assisted technology was developed to address the limitations of conventional laparoscopy. The robotic articulating laparoscopic instruments recreate the seven degrees of freedom of the human hand, thus providing the dexterity and precise movements that are lacking in laparoscopic instruments. The 3-dimensional view and magnification of the operative field enhances visual perception while complex algorithms minimize physiologic tremor.(13) These features allow the surgeon to perform delicate tissue dissection and precise intracorporeal suturing. Theoretical advantages of robotic surgery allow for resections of lesions adjacent to major vessels, near the liver hilum, and with generally more complex anatomy.(14) As a result, robotic surgery has expanded the scope of surgical procedures that can be performed through minimally invasive techniques. (1517) It is still important to note that robot-assisted technology should be viewed as an advanced tool to improve the minimally invasive approach for complex procedures.

At present, the application of robot-assisted laparoscopic surgery in liver surgery remains largely unanswered. What follows is a review of the current state of the literature concerning robot assisted liver resection.

METHODS

A literature search was performed using PUBMED for cited publications in English using key phrases “robotic liver surgery”, “robotic hepatic surgery”, “robotic liver resection”, “robotic hepatic resection”, and “robotic liver”. Using these key terms, over 70 publications were identified, which included reviews and descriptions of robotic surgery overall. Following a screen of all results, a total 25 publications relevant to robotic liver surgery were found, 9 of which contained unique patient data for patients undergoing robotic liver resections only for benign and malignant lesions.

To date, no prospective trials comparing open vs. robot-assisted or laparoscopic vs. robot-assisted has been reported. As such, the current body of literature will be collectively reviewed in order to present the contemporary view of short term outcomes, including operative time, estimated blood loss, length of stay and morbidity and mortality. Reports including patients undergoing combined resections were excluded from the comparative review. Table I represents the 9 publications identified.

Table 1.

Publications with reported robotic liver resection

Authors Year Country Study Type # Pts Malignant Benign
Lai et al(24) 2011 China Case series 10 9 1
Giulianotti et al(25) 2011 USA/Italy Case series 70 42 28
Chan et al(14) 2011 China Case series 27 21 6
Ji et al(23) 2011 China Comparative 13 8 5
Wakabayashi et al(26) 2011 Japan Case series 4 3 1
Berber et al(20) 2010 USA Comparative 9 9 0
Giulianotti et al(27) 2010 USA Case report 1 1 0
Tomulescu et al(28) 2009 Romania Case series 7 7 0
Choi et al(22) 2008 Korea Case series 3 2 1

RESULTS

Robotic Liver Surgery – Cohort Analysis

Following review of the reported literature, 9 case reports/series were identified which contained the unique patient cohort utilized for analysis. Overall, 70% of lesions resected were reported as malignant, with hepatocellular carcinoma the most frequently recorded (Table 2). Colorectal metastases accounted for the next largest group, representing 20% of the cases reported. Other HPB metastases, including 5 cases of cholangiocarcinoma, 4 cases of gallbladder cancer, and 1 hepatoblastoma, represented the next largest group. The most common benign lesions were hemagiomas, representing 10% of the robot-assisted liver resections performed for benign disease. Focal nodular hyperplasia (6%), followed by adenoma (5%) was the next most common benign lesions reported.

Table 2.

Resected Lesion Type

Benign Lesions (%) Malignant Lesions (%)
Hemangioma – 10% Hepatocellular Cancer - 27%
Focal Nodular Hyperplasia – 6% Colorectal Mets – 20%
Adenoma – 5% Primary HPB – 8%
Recurrent pyogenic abscess – 3% Other Mets – 8%
Hepaolithiasis – 1% Not Documented – 7%
Not Documented – 4%

Primary HPB included – 5 cases of cholangiocarcinoma, 4 cases of gallbladder cancer, and 1 case of hepatoblastoma

Table 3 demonstrates the frequency and type of robot-assisted resection. Left lateral sectionectomy was the most common resection, reported in 37 (26%) cases. Right hepatectomy and left hepatectomy accounted for 19% and 11%, respectively. Furthermore, reports of both extended right hepatectomy (2%) and extended left hepatectomy (1%) with biliary reconstruction were included.

Table 3.

Types of Robotic Resections

Total Cases 144
Left Lateral Sectionectomy 37 26%
Segmentectomy 34 24%
Right hepatectomy 28 19%
Left hepatectomy 16 11%
Wedge resection 15 10%
Bisegmentectomy 10 7%
Extended right hepatectomy 3 2%
Extended left hepatectomy 1 1%

Operative Time

All nine cases series reviewed reported robotic operative times and are summarized in Table 4. Given the heterogeneous types of resections performed, it is difficult to analyze and adequately draw comparisons. Moreover, methods for reporting OR times were not clearly defined. As a result, further conclusions cannot made regarding trends to decreased OR times with increased experience, as previously demonstrated throughout the laparoscopic liver resection literature.(8) Of the reports analyzed, OR times were reported with a range of 90 minutes to 720 minutes. In regards to major resections (> 3 segments), Giulianotti et al reported median OR times of 313 minutes (range 220–480) for the 27 major resections analyzed. These results were comparable to Ji et al who reported mean OR times of 338 minutes (range 150–720), in which the majority of their resections were considered major. When considering minor resections (≤ 3 segments), Giulianotti reported median OR times of 198 minutes (range 90–459). The timing for minor resections remained relatively consistent across studies analyzed, with Chan et al reporting OR times of 200 minutes (range 90–307) and Tomulescu et al reporting OR times of 137 minutes (range 120–180).

Table 4.

Primary Outcome Measures

Publication # of pts OR Time (min) EBL (mL) Length of Stay (days) Transfusion
Lai et al(24) 10 347 ±85.9 407 ±286.8 6.7±3.5 1
Giulianotti et al(25) 70 270 (90–660) 262 (20–2000) 7 (2–26) 15
Chan et al(14) 27 200 (90–307) 50(5–1000) 5.5(3–11) -
Ji et al(23) 13 338(150–720) 280 6.7 0
Wakabayashi et al(26) 4 272 Negligible - -
Berber et al(20) 9 259 ±28 136 ±61 - -
Giulianotti et al(27) 1 540 800 11 1
Tomulescu et al(28) 7 137 (120–180) - 11(4–19) -
Choi et al(22) 3 463 367 3 1

When retrospectively compared, Berber et al found no significant difference in OR times between robotic resections (259 ±28 minutes) and laparoscopic resections (234 ± 16 minutes) when comparing 9 robotic cases and 11 laparoscopic cases. However, Ji et al noted a difference when comparing robot-assisted (338 min) to laparoscopic (130 min) to open (205 min). This comparison was based on 13 robot-assisted cases, 20 laparoscopic cases, and 32 open cases.

Overall, there did not appear to be a decrease in OR time in the largest series of patients. Nonetheless, the heterogeneity of reporting and “learning curve” likely contribute to this phenomenon. When comparing the early results of robot-assisted liver surgery to the aggregate worldwide laparoscopic experience(8), operative time rangers were slightly wider (90 minutes to 720 minutes vs. 99 minutes to 331 minutes). As increased experience is accrued, these differences will likely lessen as instrumentation and surgical team experience continues to improve.

Estimated Blood Loss (EBL)

Intraoperative blood loss was reported in 8 of the studies analyzed (Table 4). Blood loss ranged from 5 mL to 2000 mL. When initially evaluating EBL as a surrogate marker for experience, there again appears to be no correlation. The authors of the larger case series did not report decreased EBL as experience increased. However, Giulianotti et al demonstrated several differences when comparing both resection type and associated pathology. When analyzing their data, major resections had a median EBL of 300 mL (range 100–2000) with a transfusion rate of 22%. This was compared to a minor resection EBL of 150 mL (range 20–1800) with a transfusion rate of 21%. Furthermore, a higher EBL was associated with liver resections in cirrhotic patients. There was an EBL of 400 mL (range 100–1800) with 6 patients requiring transfusions. Comparatively, Ji et al reported a median EBL of 280 mL in a cohort of resections that consisted of a majority of major liver resections. As previously, in a retrospective comparative analysis, Berber et al found no significant difference in EBL when comparing robot-assisted (136±61 mL) to laparoscopic (155±54 mL) when comparing 9 robot-assisted liver resections to 23 laparoscopic liver resections. Overall, the results of the robot-assisted cohort did not differ significantly when compared to the reported laparoscopic literature, where EBL ranged from 50 to 659 mL. As previously demonstrated by Topal et al(18), EBL was significantly reduced in patients undergoing laparoscopic liver resection when compared to open resection. Although no definitive data has yet to be reported, it is most likely that the robot- assisted approach will have a similar EBL profile to laparoscopy.

Length of Stay

Length of stay was reported in 7 of the publications reviewed. LOS ranged from 3–26 days. When comparing the two largest cohorts, LOS was comparable with 5.5 days (range 3–11)(14) and 7 days (range 2–26)(19). Guilianotti et al represents a unique perspective as two patient cohorts from two different countries. Their group reported a median hospital stay of 7 days for the entire series, but median hospital stay of 7 days (range 4–15) in the Italian cohort and 5 days (range 2–8) in the United States cohort. Furthermore, minor resections in Italy resulted in a median postoperative duration of 7 days (range 4–15) and major resections required 10 (range 5–23), while in the US group, the median hospital stay was 5 days (range 2–7) for minor resection and 6 days (range 4–8) for major resections. Previous authors have noted that, while the exact reasons are unknown, the variability of hospital stays may be due to a cultural and health system bias. As demonstrated in both the laparoscopic and robotic literature, the average LOS typically represent a shorter length of stay in the United States and longer length in Europe and Asia.

Complications and Conversions

The overall complication rate for the nine series analyzed was 14.6% (Table 5), which is comparable to the laparoscopic liver resection literature, which cites a complication rate of 10.5%.(8). The most common complication noted was bile leak, occurring in 6 patients included in the study. Out of the 6 that occurred, 4 resolved spontaneously and resolved with drains placed intra-operatively. Two bile leaks required percutaneous intervention postoperatively. Furthermore, none of the complications required re-operation. The review of the laparoscopic literature demonstrated an increased tendency of complications after liver resection for hepatocellular cancer (50%) compared to colorectal metastasis (11%), citing the underlying liver disease as the most likely culprit. The current body of literature for robot-assisted liver surgery did not differentiate the occurrence of complications as a function of the underlying pathology.

Table 5.

Reported Complications and Conversions (N=144)

Deaths 0
Complications 21 14.6%
Liver-Related Complications
 Bile Leak 6 4%
 Transient Liver Failure 2 1.4%
 Ascites 1 0.7%
Surgical-Related Complications
 Pleural Effusion 3 2%
 Wound infection 1 0.7%
 Ileus 1 0.7%
 Urinary Bladder Injury 1 0.7%
 Thoracic Empyema 1 0.7%
 Intra-abdominal Collection 1 0.7%
General Complications
 Transient Ischemic Attack 2 1.4%
 Deep Vein Thrombosis 2 1.4%
Conversions 6 4.2%
 Open 5 3.5%
 Hand Port 1 0.7%

Overall, there were 6 conversions (Table 5). Five patients were converted to open surgery and one was converted to a hand-assisted approach. The reasons noted for conversion included: difficulty in controlling bleeding from the left hepatic vein during a left lobectomy of a cirrhotic liver(19), an injury to the hepatic venous branches during a wedge resection resulting in a hand-port conversion(14), and non-specified bleeding(20). The three remaining conversions were due to maintaining the oncologic principles in safe removal of the liver tumor.(19) There were no reported deaths.

Oncologic Outcomes

Based on a metaanalysis of laparoscopic versus open liver resection, (21) there was comparable overall and disease-free survival when comparing laparoscopic to open liver resection. Moreover, operative blood loss and hospital length of stay was significantly less in the laparoscopic group, even when matched for extent of resection and presence of malignancy. Currently, given its novelty, there is no long-term data regarding oncologic outcomes for robot-assisted liver surgery. Lai et al. reported that 9 of their ten patients underwent operations for malignant tumors. Six patients had R0 resections while 3 patients had R1 resections. The authors further explain that two of the three patients with R1 resections had bilobar colorectal liver metastases, and hemihepatectomies were combined with RFA to manage the bilobar disease. In their cohort of 6 with R0 resection, only one patient had local recurrence.

The remaining publications that reported resection margins for malignant disease reported negative margins.(19, 20, 22, 23) Berber et al reported a mean resection margin of 11+8 mm for robotic resection and 14 + 10 mm for laparoscopic resection. Giulianotti reported 18mm (range 1–70) for all malignant lesions, further breaking down based on tumor type. The overall recurrence rate that was reported in the literature was 15%, as reported by only 4 publications. (19, 20, 22, 23) None of the publications reported port site recurrences.

DISCUSSION

Despite the explosion of reports of the feasibility and safety of laparoscopic surgery, the indications for liver resection should remain unchanged. As articulated by the Louisville Consensus(12), minimally invasive liver resection surgery requires expertise in open hepatic resection surgery, minimally invasive surgery, and laparoscopic ultrasonography. Robotic-assisted laparoscopic liver surgery has received increased attention as a result of advancement in technology. With the refinement of technology, easier set-up, better image quality, and smaller robotic systems, there has been recent interest in utilizing the robot for complex hepatobiliary procedures. By combining the efficacy of open surgery with a minimally invasive approach, the surgical robotic system allows for technical refinements of laparoscopic hepatectomy.

The current state of literature for robotic-assisted liver resection remains limited. Robot-assisted liver resection appears to be comparable to its laparoscopic and open counterpart in many regards, including operating room time, estimated blood loss, length of stay and complications. Many questions remained unanswered, most notably, its efficacy in regards to long term oncologic outcomes. Nonetheless, analysis of the current available short-term data demonstrates noninferiority to its laparoscopic and open equivalents. It is certain that future well-organized studies will be necessary to adequately evaluate short and long term outcomes.

CONCLUSION

The current state of literature demonstrates that robot-assisted liver surgery is a feasible and safe tool. Minimally invasive liver surgery is best performed by individuals trained in open liver surgery who are facile with minimally invasive techniques. The robot platform helps to overcome the inherent limitations of laparoscopy, thus expanding the role of minimally invasive surgery for complex hepatobiliary procedures. While it is evident that robot-assisted liver surgery is feasible, the overall efficacy in regards to patient outcomes remains largely unanswered. Future studies will help elucidate this question.

References

  • 1.Muhe E. Laparoscopic cholecystectomy. Z Gastroenterol Verh. 1991 Mar;26:204–6. [PubMed] [Google Scholar]
  • 2.Wilhelm T, Metzig A. Endoscopic minimally invasive thyroidectomy (eMIT): a prospective proof-of-concept study in humans. World J Surg. Mar;35(3):543–51. doi: 10.1007/s00268-010-0846-0. [DOI] [PubMed] [Google Scholar]
  • 3.Atluri P, Woo YJ. Minimally invasive robotic mitral valve surgery. Expert Rev Med Devices. Jan;8(1):115–20. doi: 10.1586/erd.10.66. [DOI] [PubMed] [Google Scholar]
  • 4.Martel G, Boushey RP. Laparoscopic colon surgery: past, present and future. Surg Clin North Am. 2006 Aug;86(4):867–97. doi: 10.1016/j.suc.2006.05.006. [DOI] [PubMed] [Google Scholar]
  • 5.Levy RM, Wizorek J, Shende M, Luketich JD. Laparoscopic and thoracoscopic esophagectomy. Adv Surg. 44:101–16. doi: 10.1016/j.yasu.2010.05.002. [DOI] [PubMed] [Google Scholar]
  • 6.Gagner MRM, Dubuc J. Laparoscopic partial hepatectomy for liver tumor _abstract_. Surg Endosc. 1992;6(99) [Google Scholar]
  • 7.Cherqui D, Husson E, Hammoud R, Malassagne B, Stephan F, Bensaid S, et al. Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg. 2000 Dec;232(6):753–62. doi: 10.1097/00000658-200012000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009 Nov;250(5):831–41. doi: 10.1097/SLA.0b013e3181b0c4df. [DOI] [PubMed] [Google Scholar]
  • 9.Abdel-Atty MY, Farges O, Jagot P, Belghiti J. Laparoscopy extends the indications for liver resection in patients with cirrhosis. Br J Surg. 1999 Nov;86(11):1397–400. doi: 10.1046/j.1365-2168.1999.01283.x. [DOI] [PubMed] [Google Scholar]
  • 10.Gayet B, Cavaliere D, Vibert E, Perniceni T, Levard H, Denet C, et al. Totally laparoscopic right hepatectomy. Am J Surg. 2007 Nov;194(5):685–9. doi: 10.1016/j.amjsurg.2006.11.044. [DOI] [PubMed] [Google Scholar]
  • 11.Gumbs AA, Bar-Zakai B, Gayet B. Totally laparoscopic extended left hepatectomy. J Gastrointest Surg. 2008 Jul;12(7):1152. doi: 10.1007/s11605-007-0461-z. [DOI] [PubMed] [Google Scholar]
  • 12.Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009 Nov;250(5):825–30. doi: 10.1097/sla.0b013e3181b3b2d8. [DOI] [PubMed] [Google Scholar]
  • 13.Idrees K, Bartlett DL. Robotic liver surgery. Surg Clin North Am. Aug;90(4):761–74. doi: 10.1016/j.suc.2010.04.020. [DOI] [PubMed] [Google Scholar]
  • 14.Chan OC, Tang CN, Lai EC, Yang GP, Li MK. Robotic hepatobiliary and pancreatic surgery: a cohort study. J Hepatobiliary Pancreat Sci. Jul;18(4):471–80. doi: 10.1007/s00534-011-0389-2. [DOI] [PubMed] [Google Scholar]
  • 15.Zeh HJ, Zureikat AH, Secrest A, Dauoudi M, Bartlett D, Moser AJ. Outcomes After Robot-Assisted Pancreaticoduodenectomy for Periampullary Lesions. Ann Surg Oncol. Sep 24; doi: 10.1245/s10434-011-2045-0. [DOI] [PubMed] [Google Scholar]
  • 16.Tatooles AJ, Pappas PS, Gordon PJ, Slaughter MS. Minimally invasive mitral valve repair using the da Vinci robotic system. Ann Thorac Surg. 2004 Jun;77(6):1978–82. doi: 10.1016/j.athoracsur.2003.11.024. discussion 82–4. [DOI] [PubMed] [Google Scholar]
  • 17.Coelho RF, Rocco B, Patel MB, Orvieto MA, Chauhan S, Ficarra V, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol. Dec;24(12):2003–15. doi: 10.1089/end.2010.0295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Topal B, Fieuws S, Aerts R, Vandeweyer H, Penninckx F. Laparoscopic versus open liver resection of hepatic neoplasms: comparative analysis of short-term results. Surg Endosc. 2008 Oct;22(10):2208–13. doi: 10.1007/s00464-008-0023-9. [DOI] [PubMed] [Google Scholar]
  • 19.Giulianotti PC, Giacomoni A, Coratti A, Addeo P, Bianco FM. Minimally invasive sequential treatment of synchronous colorectal liver metastases by laparoscopic colectomy and robotic right hepatectomy. Int J Colorectal Dis. Dec;25(12):1507–11. doi: 10.1007/s00384-010-1000-z. [DOI] [PubMed] [Google Scholar]
  • 20.Berber E, Akyildiz HY, Aucejo F, Gunasekaran G, Chalikonda S, Fung J. Robotic versus laparoscopic resection of liver tumours. HPB (Oxford) Oct;12(8):583–6. doi: 10.1111/j.1477-2574.2010.00234.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Simillis C, Constantinides VA, Tekkis PP, Darzi A, Lovegrove R, Jiao L, et al. Laparoscopic versus open hepatic resections for benign and malignant neoplasms--a meta-analysis. Surgery. 2007 Feb;141(2):203–11. doi: 10.1016/j.surg.2006.06.035. [DOI] [PubMed] [Google Scholar]
  • 22.Choi SB, Park JS, Kim JK, Hyung WJ, Kim KS, Yoon DS, et al. Early experiences of robotic-assisted laparoscopic liver resection. Yonsei Med J. 2008 Aug 30;49(4):632–8. doi: 10.3349/ymj.2008.49.4.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ji WB, Wang HG, Zhao ZM, Duan WD, Lu F, Dong JH. Robotic-assisted laparoscopic anatomic hepatectomy in China: initial experience. Ann Surg. Feb;253(2):342–8. doi: 10.1097/SLA.0b013e3181ff4601. [DOI] [PubMed] [Google Scholar]
  • 24.Lai EC, Tang CN, Li MK. Robot-assisted laparoscopic hemi-hepatectomy: Technique and surgical outcomes. Int J Surg. Nov 3; doi: 10.1016/j.ijsu.2011.10.005. [DOI] [PubMed] [Google Scholar]
  • 25.Giulianotti PC, Coratti A, Sbrana F, Addeo P, Bianco FM, Buchs NC, et al. Robotic liver surgery: results for 70 resections. Surgery. Jan;149(1):29–39. doi: 10.1016/j.surg.2010.04.002. [DOI] [PubMed] [Google Scholar]
  • 26.Wakabayashi G, Sasaki A, Nishizuka S, Furukawa T, Kitajima M. Our initial experience with robotic hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci. Jul;18(4):481–7. doi: 10.1007/s00534-011-0388-3. [DOI] [PubMed] [Google Scholar]
  • 27.Giulianotti PC, Sbrana F, Bianco FM, Addeo P. Robot-assisted laparoscopic extended right hepatectomy with biliary reconstruction. J Laparoendosc Adv Surg Tech A. Mar;20(2):159–63. doi: 10.1089/lap.2009.0383. [DOI] [PubMed] [Google Scholar]
  • 28.Tomulescu V, Stanciulea O, Balescu I, Vasile S, Tudor S, Gheorghe C, et al. First year experience of robotic-assisted laparoscopic surgery with 153 cases in a general surgery department: indications, technique and results. Chirurgia (Bucur) 2009 Mar-Apr;104(2):141–50. [PubMed] [Google Scholar]

RESOURCES